| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |